Revolution Medicines (RVMD) Goodwill & Intangibles (2019 - 2026)
Revolution Medicines (RVMD) recorded quarterly Goodwill & Intangibles of $70.4 million in Q1 2026, down 9.6% quarter-over-quarter from $77.9 million in Q4 2025, and down 0.85% on a YoY basis from $71.0 million in Q1 2025.
Revolution Medicines (RVMD) Goodwill & Intangibles (2019 - 2026) Analysis & Trends
Revolution Medicines' Goodwill & Intangibles history runs 8 years deep, the most recent figure standing at $70.4 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles fell 0.85% year-over-year to $70.4 million; the TTM figure through Mar 2026 stood at $70.4 million (down 0.85% YoY), while the FY2025 annual figure was $77.9 million, up 9.27% from the prior year.
- Goodwill & Intangibles was $70.4 million for Q1 2026 at Revolution Medicines, down from $77.9 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $77.9 million in Q2 2022 to a low of $14.7 million in Q3 2025.
- Historically, Goodwill & Intangibles has averaged $70.0 million across 5 years, with a median of $71.0 million in 2025.
- The sharpest annual moves came in 2022 and 2025: Goodwill & Intangibles grew 10.62% in 2022, then plunged 81.16% in 2025.
- A 5-year view of Goodwill & Intangibles shows it stood at $70.4 million in 2022, then gained by 10.62% to $77.9 million in 2023, then retreated by 8.49% to $71.3 million in 2024, then increased by 9.27% to $77.9 million in 2025, then retreated by 9.6% to $70.4 million in 2026.
- The last three Goodwill & Intangibles figures came in at $70.4 million (Q1 2026), $77.9 million (Q4 2025), and $14.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Revolution Medicines | 32.33 Bn | 32.33 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.41 Mn |
| Dec 31, 2025 | 77.89 Mn |
| Sep 30, 2025 | 14.68 Mn |
| Jun 30, 2025 | 70.41 Mn |
| Mar 31, 2025 | 71.01 Mn |
| Dec 31, 2024 | 71.28 Mn |
| Sep 30, 2024 | 77.89 Mn |
| Jun 30, 2024 | 77.89 Mn |
| Mar 31, 2024 | 70.41 Mn |
| Dec 31, 2023 | 77.89 Mn |
| Sep 30, 2023 | 72.61 Mn |
| Jun 30, 2023 | 70.41 Mn |
| Mar 31, 2023 | 70.41 Mn |
| Dec 31, 2022 | 70.41 Mn |
| Sep 30, 2022 | 77.89 Mn |
| Jun 30, 2022 | 77.89 Mn |
| Mar 31, 2022 | 70.41 Mn |
| Dec 31, 2021 | 70.41 Mn |
| Sep 30, 2021 | 77.89 Mn |
| Jun 30, 2021 | 70.41 Mn |